BANQUE PICTET & CIE SA

Position in IMVT — Immunovant, Inc.

CIK 1535602 GENEVA 73, V8

Position in IMVT

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$2,203,530

+$1,216 QoQ

Shares Held

57,190

-35.5% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#82

of 224 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BANQUE PICTET & CIE SA holds $213,407,213 across 8 Biotechnology names. IMVT ranks #6 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	2,699,402	$189,039,122
2	VRTX	Vertex Pharmaceuticals Inc / Ma	23,496	$11,671,168
3	PCVX	Vaxcyte, Inc.	44,736	$2,600,503
4	GPCR	Structure Therapeutics Inc.	43,332	$2,325,628
5	REGN	Regeneron Pharmaceuticals, Inc.	3,713	$2,315,204
6	IMVT	Immunovant, Inc. This page	57,190	$2,203,530
7	BNTX	BioNTech SE	17,705	$1,647,450
8	AVIR	Atea Pharmaceuticals, Inc.	345,077	$1,604,608

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,203,530	57,190	-35.5%	Shares	Sole	2026-07-24
2026-03-31	$2,202,314	88,660	-22.8%	Shares	Sole	2026-04-14
2025-12-31	$2,920,275	114,881	+0.9%	Shares	Sole	2026-01-16
2025-09-30	$1,835,874	113,888	-9.6%	Shares	Sole	2025-10-21
2025-06-30	$2,015,232	125,952	-14.5%	Shares	Sole	2025-07-16
2025-03-31	$2,519,014	147,397	+1.3%	Shares	Sole	2025-04-30
2024-12-31	$3,603,539	145,480	-8.5%	Shares	Sole	2025-01-30
2024-09-30	$4,530,809	158,920	+133.2%	Shares	Sole	2024-10-21
2024-06-30	$1,799,212	68,152	-3.1%	Shares	Sole	2024-07-25
2024-03-31	$2,271,683	70,309	-8.7%	Shares	Sole	2024-05-06
2023-12-31	$3,245,316	77,031	—	Shares	Sole	2024-02-09
No filing history on record for this holder in this stock.